Treatment of lower-risk myelodysplastic syndromes
Myelodysplastic neoplasms (MDS) involve clonal hematopoiesis and cellular dysplasia, driven by genetic and epigenetic alterations. Spliceosome mutations and epigenetic dysregulation underscore the intricate pathogenesis of MDS. The bone marrow microenvironment, stromal dysfunction, chronic inflamma...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Ferrata Storti Foundation
2024-10-01
|
| Serie: | Haematologica |
| Accesso online: | https://haematologica.org/article/view/11799 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|